Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

0.1780 +0.0060 (+3.49%)
Streaming Delayed Price Updated: 10:40 AM EDT, Sep 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,392,934
Open 0.1720
Bid (Size) 0.1770 (1,000)
Ask (Size) 0.1795 (500)
Prev. Close 0.1720
Today's Range 0.1698 - 0.1820
52wk Range 0.1512 - 3.050
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
Company prioritizes CD228V precision oncology development in Melanoma while pursuing capital-efficient partnerships for SkinJect® and Teverelix® indications 
From Medicus Pharma Ltd
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill

Performance

YTD
-88.9%
-88.9%
1 Month
-44.7%
-44.7%
3 Month
-47.1%
-47.1%
6 Month
-65.8%
-65.8%
1 Year
-91.5%
-91.5%

More News

Read More
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
Gapping stocks in Thursday's session ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Medicus Pharma Ltd
Via ACCESS Newswire
News headline image
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
From New to The Street
Via ACCESS Newswire
Top movers in Friday's after hours session ↗
Via Chartmill
News headline image
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
Via Chartmill
News headline image
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
From New to The Street
Via ACCESS Newswire
News headline image
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
From New to The Street
Via ACCESS Newswire
News headline image
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
Via ACCESS Newswire
News headline image
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Graphene Manufacturing (OTCQX: GMGMF) (TSXV: GMG) Showcases Next-Generation Energy Storage and Graphene Innovation on Bloomberg TV – See INHD, SUNE, TDIC, DOSE Inside
Via AB Newswire
Topics Artificial Intelligence Energy
News headline image
Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
Via ACCESS Newswire
News headline image
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
From Medicus Pharma Ltd
Via GlobeNewswire

Frequently Asked Questions

Is Medicus Pharma Ltd. - Common Stock publicly traded?
Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
What exchange does Medicus Pharma Ltd. - Common Stock trade on?
Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
What is the current price of Medicus Pharma Ltd. - Common Stock?
The current price of Medicus Pharma Ltd. - Common Stock is 0.1780
When was Medicus Pharma Ltd. - Common Stock last traded?
The last trade of Medicus Pharma Ltd. - Common Stock was at 09/08/26 10:40 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.